Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Vacuolar protein sorting protein 41 (VPS41) at an intersection of endosomal traffic in neurodegenerative disease.

Griffin EF, Caldwell KA, Caldwell GA.

Neural Regen Res. 2019 Jul;14(7):1210-1212. doi: 10.4103/1673-5374.251329. No abstract available.

2.

ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans.

Griffin EF, Scopel SE, Stephen CA, Holzhauer AC, Vaji MA, Tuckey RA, Berkowitz LA, Caldwell KA, Caldwell GA.

Dis Model Mech. 2019 Feb 15;12(2). pii: dmm037218. doi: 10.1242/dmm.037218.

3.

Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.

Griffin EF, Yan X, Caldwell KA, Caldwell GA.

Hum Mol Genet. 2018 Dec 15;27(24):4176-4193. doi: 10.1093/hmg/ddy308.

PMID:
30508205
4.

Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.

Griffin EF, Caldwell KA, Caldwell GA.

ACS Chem Neurosci. 2017 Dec 20;8(12):2596-2606. doi: 10.1021/acschemneuro.7b00361. Epub 2017 Oct 25. Review.

PMID:
29022701
5.

Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.

Price KE, Naimie AA, Griffin EF, Bay C, O'Toole GA.

J Bacteriol. 2015 Oct 19;198(2):237-47. doi: 10.1128/JB.00705-15. Print 2016 Jan 15.

6.

Minor pilins of the type IV pilus system participate in the negative regulation of swarming motility.

Kuchma SL, Griffin EF, O'Toole GA.

J Bacteriol. 2012 Oct;194(19):5388-403. doi: 10.1128/JB.00899-12. Epub 2012 Aug 3.

7.

In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.

Yu Q, Griffin EF, Moreau-Marquis S, Schwartzman JD, Stanton BA, O'Toole GA.

J Antimicrob Chemother. 2012 Nov;67(11):2673-81. doi: 10.1093/jac/dks296. Epub 2012 Jul 26.

8.

Treatment of patients with the hypereosinophilic syndrome with mepolizumab.

Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, Schwartz LB, Rosenwasser LJ, Ring J, Griffin EF, Haig AE, Frewer PI, Parkin JM, Gleich GJ; Mepolizumab HES Study Group.

N Engl J Med. 2008 Mar 20;358(12):1215-28. doi: 10.1056/NEJMoa070812. Epub 2008 Mar 16. Erratum in: N Engl J Med. 2008 Jun 5;358(23): 2530.

9.

Competency to stand trial in preadjudicated and petitioned juvenile defendants.

Baerger DR, Griffin EF, Lyons JS, Simmons R.

J Am Acad Psychiatry Law. 2003;31(3):314-20.

PMID:
14584530

Supplemental Content

Loading ...
Support Center